Skip to main content
Market intelligence
CYTKHealthcare

Cytokinetics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 18, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3,500$75.82$265,370
Aug 10, 2026Robert I BlumPresident & CEOSale7,500$76.76$575,700
Jul 30, 2026Andrew CallosEVP, Chief Commercial OfficerSale14,000$79.88$1,118,320